Published in Lakartidningen on April 21, 1999
Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ (1992) 6.33
Cardiovascular disease in developing countries. BMJ (1993) 1.59
[Fatty acids and confusing signals]. Ugeskr Laeger (1995) 1.40
Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin A- contaminated feed. Acta Pathol Microbiol Scand Suppl (1974) 1.33
Glomerulonephritis and exposure to organic solvents. A case-control study. Acta Med Scand (1979) 1.24
Quotation bias in reviews of the diet-heart idea. J Clin Epidemiol (1995) 1.11
Hydrocarbon exposure and glomerulonephritis: evidence from patients' occupations. Lancet (1983) 1.10
Treatment of glomerulonephritis with drainage of the thoracic duct and plasmapheresis. Acta Med Scand (1977) 1.08
Improvement of glomerulonephritis after discontinuation of solvent exposure. Lancet (1979) 1.08
[The Scandinavian Simvastatin Survival Study (4S): hasty conclusions]. Ugeskr Laeger (1995) 1.07
[Stop the cholesterol campaign!]. Lakartidningen (1993) 1.07
The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis. Clin Nephrol (1981) 1.02
alpha1-Microglobulin, a new low molecular weight plasma protein. Clin Chim Acta (1976) 0.97
Exposure to organic solvents--a missing link in poststreptococcal glomerulonephritis? Acta Med Scand (1978) 0.96
Aneurysm of the heart and the post-myocardial infarction syndrome. Acta Med Scand (1968) 0.92
What do angiographic changes after cholesterol lowering mean? Lancet (1994) 0.92
Implications of 4S evidence on baseline lipid levels. Lancet (1995) 0.90
Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism. Br J Clin Pharmacol (1999) 0.88
Experimental porcine nephropathy: changes of renal function and structure perorally induced by crystalline ochratoxin A. Acta Pathol Microbiol Scand A (1976) 0.88
Porcine nephropathy induced by long-term ingestion of ochratoxin A. Vet Pathol (1979) 0.87
Renal handling of Zn-alpha2-glycoprotein as compared with that of albumin and the retinol-binding protein. J Clin Invest (1976) 0.84
Possible mechanisms of hydrocarbon-associated glomerulonephritis. Clin Nephrol (1985) 0.82
The serum level and urinary excretion of 2 -microglobulin, 2 -microglobulin and lysozyme in renal disease. Scand J Urol Nephrol (1972) 0.81
Focal glomerular lesions in glomerulonephritis may be secondary to tubulointerstitial damage. Am J Kidney Dis (1988) 0.80
Glomerulonephritis, renal carcinoma, and solvent exposure: bias from choice of referents. Br J Ind Med (1990) 0.79
Influence of hydrocarbon exposure on the course of glomerulonephritis. Nephron (1986) 0.79
Letter: Serum beta2-microglobulin and glomerular function. N Engl J Med (1976) 0.78
Renal extraction of 2 -microglobulin. Scand J Clin Lab Invest (1972) 0.78
The subepithelial formation of immune complexes in membranous glomerulonephritis may be harmless and secondary to toxic or allergic factors. Scand J Immunol (1998) 0.78
Non-systemic glomerulonephritis: exposure to nephro- and immunotoxic chemicals predispose to immunologic harassment. Med Hypotheses (1989) 0.78
Suicide of the nephron is preventable. Lancet (2001) 0.77
American College of Physicians guidelines on cholesterol screening. Ann Intern Med (1996) 0.76
Frequency of citation and outcome of cholesterol lowering trials. BMJ (1992) 0.76
Why heart disease mortality is low in France. Authors' hypothesis is wrong. BMJ (1999) 0.75
Beneficial effects of simvastatin may be due to non-lipid actions. BMJ (1995) 0.75
An elevated serum cholesterol level is secondary, not causal, in coronary heart disease. Med Hypotheses (1991) 0.75
[Uncritical review of articles on cholesterol]. Ugeskr Laeger (1994) 0.75
Reducing serum cholesterol. Lower cholesterol of doubtful benefit to anyone. BMJ (1993) 0.75
Hydrocarbons and renal failure: primary damage in glomerulonephritis is tubular, not glomerular. Nephron (1992) 0.75
VAT and fat. Evidence is contradictory. BMJ (2000) 0.75
Cholesterol and all-cause mortality in Honolulu. Lancet (2001) 0.75
Hypercholesterolemia does not cause coronary heart disease--evidence from the nephrotic syndrome. Nephron (1994) 0.75
Prevention of atherosclerosis in children. Lancet (2000) 0.75
Ischaemic heart disease and cholesterol. Optimism about drug treatment is unjustified. BMJ (1994) 0.75
Is intake of trans-fatty acids and saturated fat causal in coronary heart disease? Circulation (1994) 0.75
[Do polyunsaturated fats cause male sterility?]. Lakartidningen (1994) 0.75
[What is the correct answer in the cholesterol debate?]. Ugeskr Laeger (1992) 0.75
[Doubtful advices on cholesterol screening in children]. Ugeskr Laeger (1993) 0.75
Doing the right thing: stop worrying about cholesterol. Circulation (1994) 0.75
[Decreased cholesterol level shortens life]. Ugeskr Laeger (1993) 0.75
[Osteoporosis can be iatrogenic--spare the ovary]. Lakartidningen (1993) 0.75
[The Chinese Mädchenfanger method as the best way of repositioning wrist joint fractures?]. Lakartidningen (1989) 0.75
[Bacteriuria and pyuria--is it harmful?]. Lakartidningen (1972) 0.75
Focal segmental glomerulosclerosis in acute renal failure. N Engl J Med (1989) 0.75
[Lipid lowering doesn't affect the development of atherosclerosis in peripheral artery disease]. Lakartidningen (2001) 0.75
[Long term prognosis in urinary tract infections and asymptomatic bacteriuria]. Lakartidningen (1975) 0.75
Low molecular weight proteinuria in association with paroxysmal myoglobinuria. Clin Nephrol (1975) 0.75
Hypertension and paranoid states. Lancet (1977) 0.75
[New trends from the USA. The cholesterol campaign is questioned]. Lakartidningen (1993) 0.75
[Calcifications in the conjunctiva and cornea in kidney insufficiency]. Nord Med (1971) 0.75
[Single-dose treatment of uncomplicated cystitis and asymptomatic bacteriuria--a review]. Lakartidningen (1986) 0.75
Proteinuria after human renal transplantation. II. A functional identification of two types of rejection crisis. Scand J Urol Nephrol (1974) 0.75
[Preparedness against scientific fraud]. Lakartidningen (1993) 0.75
Proteinuria after human renal transplantation. I. Urinary excretion of alpha-2-microglobulin (retinol-binding protein), beta-2-microglobulin, lysozyme and albumin. Scand J Urol Nephrol (1974) 0.75
Soap is the major cause of dysuria. Lancet (1984) 0.75
Cortical volume in apparently normal kidneys. Scand J Urol Nephrol (1972) 0.75
[Excellence of the "Mediterranean diet" is a myth. There is no evidence that monounsaturated fats prevent myocardial infarction]. Lakartidningen (1998) 0.75
Albuminuria in acute and chronic renal failure. Acta Med Scand (1973) 0.75
[Do cholesterol-lowering drugs cause cancer?]. Lakartidningen (1996) 0.75
Urinary tract infection with disappearance of urinary creatinine. Case report. Scand J Urol Nephrol (1973) 0.75
[On honesty and monounsaturated fat]. Lakartidningen (1998) 0.75
[Experts ask for priorities when it comes to interpretation. Ravnskov answers in the debate on dietary fats]. Lakartidningen (1998) 0.75
Coronary atherosclerosis on angiography--progress or regress, and why? Circulation (1993) 0.75
Uremic polyneuropathic motor paralysis and immobilization hypercalcemia. Scand J Urol Nephrol (1973) 0.75
[Are polyunsaturated fats useful?]. Lakartidningen (1991) 0.75
Proteinuria in pigs with experimentally induced renal damage. Contrib Nephrol (1975) 0.75
Muramidase and acute rejection of kidney grafts. Lancet (1972) 0.75
[Glomerulonephritis and organic solvents]. Lakartidningen (1986) 0.75
[Too optimistic view in mass media on statin treatment in acute myocardial infarction]. Lakartidningen (2001) 0.75
Gel chromatography on Sephadex gels with narrow particle size distribution obtained by dry elutriation. Anal Biochem (1976) 0.75
[Editorial: Medicated society?]. Lakartidningen (1976) 0.75
Renal handling of human beta2-microglobulin in the rat: the importance of sham-operation. Acta Physiol Scand (1975) 0.75
Low molecular weight proteinuria and slight hyperlipoproteinemia in three mentally retarded brothers. Acta Paediatr Scand (1976) 0.75
Hydrocarbon exposure and glomerulonephritis. Nephron (1984) 0.75
Acute glomerulonephritis and exposure to organic solvents in father and daughter. Acta Med Scand (1979) 0.75
[A case report of PMI (post-myocardial infarct) syndrome]. Lakartidningen (1967) 0.75